LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: Can calcium channel blockers prevent ischemic stroke in nonvalvular atrial fibrillation patients?-the optimal choice of antihypertensive drug for subtype-specific stroke prevention.

    Kiyohara, Takuya / Ago, Tetsuro

    Hypertension research : official journal of the Japanese Society of Hypertension

    2022  Volume 45, Issue 6, Page(s) 1076–1078

    MeSH term(s) Anticoagulants/adverse effects ; Antihypertensive Agents/therapeutic use ; Atrial Fibrillation/chemically induced ; Atrial Fibrillation/complications ; Atrial Fibrillation/drug therapy ; Calcium Channel Blockers/therapeutic use ; Humans ; Ischemic Stroke ; Risk Factors ; Stroke/chemically induced ; Stroke/prevention & control
    Chemical Substances Anticoagulants ; Antihypertensive Agents ; Calcium Channel Blockers
    Language English
    Publishing date 2022-04-01
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 1175297-x
    ISSN 1348-4214 ; 0916-9636
    ISSN (online) 1348-4214
    ISSN 0916-9636
    DOI 10.1038/s41440-022-00907-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Regulation of Derlin-1-mediated degradation of NADPH oxidase partner p22

    Miyano, Kei / Okamoto, Shuichiro / Kajikawa, Mizuho / Kiyohara, Takuya / Kawai, Chikage / Yamauchi, Akira / Kuribayashi, Futoshi

    Redox biology

    2022  Volume 56, Page(s) 102479

    Abstract: The transmembrane protein ... ...

    Abstract The transmembrane protein p22
    MeSH term(s) Granulomatous Disease, Chronic ; Humans ; Membrane Proteins/metabolism ; Mutant Proteins ; NADPH Oxidases/genetics ; NADPH Oxidases/metabolism ; Reactive Oxygen Species/metabolism ; Serine ; Sulfhydryl Compounds
    Chemical Substances DERL1 protein, human ; Membrane Proteins ; Mutant Proteins ; Reactive Oxygen Species ; Sulfhydryl Compounds ; Serine (452VLY9402) ; NADPH Oxidases (EC 1.6.3.-) ; CYBA protein, human (EC 1.6.3.1)
    Language English
    Publishing date 2022-09-13
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2701011-9
    ISSN 2213-2317 ; 2213-2317
    ISSN (online) 2213-2317
    ISSN 2213-2317
    DOI 10.1016/j.redox.2022.102479
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Association between Early Cognitive Impairment and Short-Term Functional Outcome in Acute Ischemic Stroke.

    Kiyohara, Takuya / Kumai, Yasuhiro / Yubi, Tomohiro / Ishikawa, Eiichi / Wakisaka, Yoshinobu / Ago, Tetsuro / Kitazono, Takanari

    Cerebrovascular diseases (Basel, Switzerland)

    2022  Volume 52, Issue 1, Page(s) 61–67

    Abstract: Background: Little is known about the association between poststroke cognitive impairment (PSCI) and functional outcome in the acute care phase of ischemic stroke and the influence of the clinical condition of acute stroke on this association. We ... ...

    Abstract Background: Little is known about the association between poststroke cognitive impairment (PSCI) and functional outcome in the acute care phase of ischemic stroke and the influence of the clinical condition of acute stroke on this association. We examined this issue, taking into account stroke-related factors, in a hospital-based prospective study of patients with acute ischemic stroke. The same analysis was also performed after subsequent rehabilitation to investigate whether the association observed in the acute care phase persisted after that. For comparison, the same analysis was performed for pre-stroke dementia (PreSD).
    Methods: We included in the study a total of 923 patients with acute ischemic stroke who were admitted to a hospital from 2012 to 2020 in Japan. Cognitive function was assessed using the Mini-Mental State Examination and Raven's Colored Progressive Matrices test at an average of 6.3 days after stroke onset. The subjects were divided into three groups with normal cognition, PSCI, and PreSD. Study outcome was a poor functional outcome, defined as a modified Rankin Scale score of ≥3 at the end of acute care (median 21 days after admission). Among total subjects, 460 were also assessed for poor functional outcome after rehabilitation (median 77 days after admission). A logistic regression model was applied in this study.
    Results: Patients with PSCI and PreSD had higher median National Institute of Health Stroke Scale scores than those with normal cognition (median [IQR]: 3 [2-6], 4 [2-12], and 2 [1-4], respectively). The age- and sex-adjusted cumulative incidence of poor functional outcome was significantly higher in patients with PSCI and PreSD than in those with normal cognition in the acute care and rehabilitation phases. In the acute care phase, these associations remained significant after adjustment for stroke-related factors and other confounders (multivariable-adjusted odds ratio [95% CI] for PSCI vs. normal cognition: 3.28 [2.07-5.20]; for PreSD: 2.39 [1.40-4.08]). Similar results were observed in the rehabilitation phase (for PSCI: 2.48 [1.31-4.70]; for PreSD: 3.92 [1.94-7.92]).
    Conclusions: Our findings suggest that PSCI, as well as PreSD, is possibly associated with the development of poor functional outcome in the acute care phase of ischemic stroke, and this association continues thereafter.
    MeSH term(s) Humans ; Ischemic Stroke/complications ; Brain Ischemia/diagnosis ; Brain Ischemia/therapy ; Brain Ischemia/complications ; Prospective Studies ; Cognitive Dysfunction/diagnosis ; Cognitive Dysfunction/etiology ; Stroke/diagnosis ; Stroke/therapy ; Stroke/complications
    Language English
    Publishing date 2022-06-03
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1069462-6
    ISSN 1421-9786 ; 1015-9770
    ISSN (online) 1421-9786
    ISSN 1015-9770
    DOI 10.1159/000524839
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Association between decreases in serum uric acid levels and unfavorable outcomes after ischemic stroke: A multicenter hospital-based observational study.

    Nakamura, Kuniyuki / Ueki, Kana / Matsuo, Ryu / Kiyohara, Takuya / Irie, Fumi / Wakisaka, Yoshinobu / Ago, Tetsuro / Kamouchi, Masahiro / Kitazono, Takanari

    PloS one

    2023  Volume 18, Issue 6, Page(s) e0287721

    Abstract: Background: The association between clinical outcomes in ischemic stroke patients and decreases in serum uric acid levels, which often occur during the acute phase, remains unknown. Herein, we aimed to investigate the association using a large-scale, ... ...

    Abstract Background: The association between clinical outcomes in ischemic stroke patients and decreases in serum uric acid levels, which often occur during the acute phase, remains unknown. Herein, we aimed to investigate the association using a large-scale, multicenter stroke registry.
    Methods: We analyzed 4,621 acute ischemic stroke patients enrolled in the Fukuoka Stroke Registry between June 2007 and September 2019 whose uric acid levels were measured at least twice during hospitalization (including on admission). The study outcomes were poor functional outcome (modified Rankin Scale score ≥3) and functional dependence (modified Rankin Scale score 3-5) at 3 months after stroke onset. Changes in uric acid levels after admission were evaluated using a decrease rate that was classified into 4 sex-specific grades ranging from G1 (no change/increase after admission) to G4 (most decreased). Multivariable logistic regression analyses were used to assess the associations between decreases in uric acid levels and the outcomes.
    Results: The frequencies of the poor functional outcome and functional dependence were lowest in G1 and highest in G4. The odds ratios (95% confidence intervals) of G4 were significantly higher for poor functional outcome (2.66 [2.05-3.44]) and functional dependence (2.61 [2.00-3.42]) when compared with G1 after adjusting for confounding factors. We observed no heterogeneity in results for subgroups categorized according to age, sex, stroke subtype, neurological severity, chronic kidney disease, or uric acid level on admission.
    Conclusions: Decreases in serum uric acid levels were independently associated with unfavorable outcomes after acute ischemic stroke.
    MeSH term(s) Female ; Male ; Humans ; Ischemic Stroke ; Uric Acid ; Hospitals ; Stroke ; Hospitalization
    Chemical Substances Uric Acid (268B43MJ25)
    Language English
    Publishing date 2023-06-29
    Publishing country United States
    Document type Observational Study ; Multicenter Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0287721
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The downregulation of NADPH oxidase Nox4 during hypoxia in hemangioendothelioma cells: a possible role of p22

    Miyano, Kei / Okamoto, Shuichiro / Yamauchi, Akira / Kawai, Chikage / Kajikawa, Mizuho / Kiyohara, Takuya / Itsumi, Momoe / Taura, Masahiko / Kuribayashi, Futoshi

    Free radical research

    2022  Volume 55, Issue 9-10, Page(s) 996–1004

    Abstract: NADPH oxidase (Nox) 4 produces ... ...

    Abstract NADPH oxidase (Nox) 4 produces H
    MeSH term(s) Animals ; Humans ; Mice ; Down-Regulation ; Hemangioendothelioma ; Hydrogen Peroxide/metabolism ; Hypoxia/genetics ; NADPH Oxidase 4/genetics ; NADPH Oxidase 4/metabolism ; NADPH Oxidases/genetics ; NADPH Oxidases/metabolism ; Protein Stability ; Reactive Oxygen Species/metabolism
    Chemical Substances Hydrogen Peroxide (BBX060AN9V) ; NADPH Oxidase 4 (EC 1.6.3.-) ; NADPH Oxidases (EC 1.6.3.-) ; NOX4 protein, human (EC 1.6.3.-) ; Nox4 protein, mouse (EC 1.6.3.-) ; Reactive Oxygen Species
    Language English
    Publishing date 2022-01-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 1194130-3
    ISSN 1029-2470 ; 1071-5762
    ISSN (online) 1029-2470
    ISSN 1071-5762
    DOI 10.1080/10715762.2021.2009116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: T2*-Weighted MRI Detected Dilated Cerebral Veins in a Patient with Acute-Phase Cerebral Venous Sinus Thrombosis-A Case Report.

    Kiyohara, Takuya / Abe, Chie / Yokoi, Mio / Sakaki, Yusuke / Kumai, Yasuhiro

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

    2019  Volume 28, Issue 8, Page(s) e116–e118

    Abstract: We describe a 45-year-old man who presented with nausea, vomiting, and strong occipital headache on the right side. Although no abnormalities on neurological examination or computed tomography imaging were found on admission, peripheral blood cell counts ...

    Abstract We describe a 45-year-old man who presented with nausea, vomiting, and strong occipital headache on the right side. Although no abnormalities on neurological examination or computed tomography imaging were found on admission, peripheral blood cell counts showed polycythemia (hemoglobin 20.6 g/dL) and electrocardiography demonstrated atrial fibrillation. Therefore, anticoagulant treatment with heparin was started immediately. On the following day, the occipital headache continued. Brain T2*-weighted (T2*WI) magnetic resonance imaging (MRI) and, to a lesser extent, susceptibility-weighted imaging showed dilation of numerous cortical veins, suggesting the possibility of cerebral venous thrombosis (CVT). MR venography (MRV) showed a deficit of the right transverse sinus. Contrast-enhanced MRI revealed partial defects of the right transverse sinus, and led to the definite diagnosis of CVT, and the anticoagulation therapy was continued. On day 7 the headache disappeared, and MRV on day 16 showed the recanalization of the right transverse sinus. There were no complications subsequent to the CVT. On day 25, the patient was discharged with no after-effect. We speculate that the dilation of cortical veins on T2*WI is a helpful sign in detecting acute-phase CVT.
    MeSH term(s) Anticoagulants/therapeutic use ; Cerebral Angiography/methods ; Cerebral Veins/diagnostic imaging ; Cerebral Veins/pathology ; Diffusion Magnetic Resonance Imaging ; Dilatation, Pathologic ; Heparin/therapeutic use ; Humans ; Magnetic Resonance Angiography ; Male ; Middle Aged ; Phlebography/methods ; Predictive Value of Tests ; Sinus Thrombosis, Intracranial/diagnostic imaging ; Sinus Thrombosis, Intracranial/drug therapy ; Sinus Thrombosis, Intracranial/pathology ; Treatment Outcome
    Chemical Substances Anticoagulants ; Heparin (9005-49-6)
    Language English
    Publishing date 2019-06-03
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1131675-5
    ISSN 1532-8511 ; 1052-3057
    ISSN (online) 1532-8511
    ISSN 1052-3057
    DOI 10.1016/j.jstrokecerebrovasdis.2019.05.024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: β-Cell Function and Clinical Outcome in Nondiabetic Patients With Acute Ischemic Stroke.

    Kiyohara, Takuya / Matsuo, Ryu / Hata, Jun / Nakamura, Kuniyuki / Wakisaka, Yoshinobu / Kamouchi, Masahiro / Kitazono, Takanari / Ago, Tetsuro

    Stroke

    2021  Volume 52, Issue 8, Page(s) 2621–2628

    Abstract: Background and purpose: Little is known about how β-cell dysfunction affects clinical outcome after ischemic stroke. We examined whether β-cell function is associated with clinical outcome after acute ischemic stroke and if so, whether insulin ... ...

    Abstract Background and purpose: Little is known about how β-cell dysfunction affects clinical outcome after ischemic stroke. We examined whether β-cell function is associated with clinical outcome after acute ischemic stroke and if so, whether insulin resistance influences this association in a prospective study of patients with acute stroke.
    Methods: A total of 3590 nondiabetic patients with acute ischemic stroke (mean age, 71 years) were followed up for 3 months. β-Cell function was assessed using the homeostasis model assessment for β-cell function (HOMA-β). Study outcomes were poor functional outcome (modified Rankin Scale score, 3–6) and stroke recurrence at 3 months after stroke onset and neurological deterioration (≥2-point increase in the National Institutes of Health Stroke Scale score) at discharge. Logistic regression analysis was used to evaluate the association between quintile levels of serum HOMA-β and clinical outcomes.
    Results: The age- and sex-adjusted odds ratios for poor functional outcome and neurological deterioration increased significantly with decreasing HOMA-β levels (P for trend, <0.001 and 0.001, respectively). These associations became more prominent after adjustment for HOMA-insulin resistance and were substantially unchanged even after further adjustment for other confounders, namely, body mass index, dyslipidemia, hypertension, estimated glomerular filtration rate, stroke subtype, National Institutes of Health Stroke Scale score on admission, and reperfusion therapy (odds ratio [95% CI] for the first versus fifth quintile of HOMA-β, 3.30 [2.15–5.08] for poor functional outcome and 10.69 [4.99–22.90] for neurological deterioration). Such associations were not observed for stroke recurrence. In stratified analysis for the combination of HOMA-β and HOMA-insulin resistance levels, lower HOMA-β and higher HOMA-insulin resistance levels were independently associated with increased risks of poor functional outcome and neurological deterioration.
    Conclusions: Our findings suggest that β-cell dysfunction is significantly associated with poor short-term clinical outcome independently of insulin resistance in nondiabetic patients with acute ischemic stroke.
    MeSH term(s) Aged ; Aged, 80 and over ; B-Lymphocytes/metabolism ; Cohort Studies ; Diabetes Mellitus ; Female ; Hospitalization/trends ; Humans ; Insulin Resistance/physiology ; Ischemic Stroke/blood ; Ischemic Stroke/diagnosis ; Male ; Middle Aged ; Prospective Studies ; Registries ; Treatment Outcome
    Language English
    Publishing date 2021-05-14
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.120.031392
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Low-dose sodium-glucose cotransporter 2 inhibitor ameliorates ischemic brain injury in mice through pericyte protection without glucose-lowering effects.

    Takashima, Masamitsu / Nakamura, Kuniyuki / Kiyohara, Takuya / Wakisaka, Yoshinobu / Hidaka, Masaoki / Takaki, Hayato / Yamanaka, Kei / Shibahara, Tomoya / Wakisaka, Masanori / Ago, Tetsuro / Kitazono, Takanari

    Communications biology

    2022  Volume 5, Issue 1, Page(s) 653

    Abstract: Antidiabetic sodium-glucose cotransporter 2 (SGLT2) inhibitors have attracted attention for their cardiorenal-protective properties beyond their glucose-lowering effect. However, their benefits in ischemic stroke remain controversial. Here we show the ... ...

    Abstract Antidiabetic sodium-glucose cotransporter 2 (SGLT2) inhibitors have attracted attention for their cardiorenal-protective properties beyond their glucose-lowering effect. However, their benefits in ischemic stroke remain controversial. Here we show the effects of luseogliflozin, a selective SGLT2 inhibitor, in acute ischemic stroke, using a permanent middle cerebral artery occlusion (pMCAO) model in non-diabetic mice. Pretreatment with low-dose luseogliflozin, which does not affect blood glucose levels, significantly attenuated infarct volume, blood-brain barrier disruption, and motor dysfunction after pMCAO. SGLT2 was expressed predominantly in brain pericytes and was upregulated in peri- and intra-infarct areas. Notably, luseogliflozin pretreatment reduced pericyte loss in ischemic areas. In cultured pericytes, luseogliflozin activated AMP-activated protein kinase α and increased mitochondrial transcription factor A expression and number of mitochondria, conferring resistance to oxygen-glucose deprivation. Collectively, pre-stroke inhibition of SGLT2 induces ischemic tolerance in brain pericytes independent of the glucose-lowering effect, contributing to the attenuation of ischemic brain injury.
    MeSH term(s) Animals ; Brain Injuries/metabolism ; Glucose/metabolism ; Infarction/metabolism ; Ischemic Stroke ; Mice ; Pericytes/metabolism ; Sodium/metabolism ; Sodium-Glucose Transporter 2/metabolism
    Chemical Substances Sodium-Glucose Transporter 2 ; Sodium (9NEZ333N27) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2022-07-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2399-3642
    ISSN (online) 2399-3642
    DOI 10.1038/s42003-022-03605-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Constitutive activity of NADPH oxidase 1 (Nox1) that promotes its own activity suppresses the colon epithelial cell migration.

    Miyano, Kei / Okamoto, Shuichiro / Yamauchi, Akira / Kajikawa, Mizuho / Kiyohara, Takuya / Taura, Masahiko / Kawai, Chikage / Kuribayashi, Futoshi

    Free radical research

    2020  Volume 54, Issue 8-9, Page(s) 640–648

    Abstract: Superoxide producing NADPH oxidase 1 (Nox1), abundantly expressed in the colon epithelium, plays a crucial role in mucosal host defenses. In this study, we found that pre-treatment of cells with edaravone, a free radical scavenger, inhibited Nox1 ... ...

    Abstract Superoxide producing NADPH oxidase 1 (Nox1), abundantly expressed in the colon epithelium, plays a crucial role in mucosal host defenses. In this study, we found that pre-treatment of cells with edaravone, a free radical scavenger, inhibited Nox1 constitutive activity even after washout without affecting Nox1 trafficking to the plasma membrane and membrane recruitment of the cytosolic regulators Noxo1 and Noxa1. These results suggest that a Nox1-derived product is involved in the step that initiates the electron transfer reaction after the formation of the Nox1-Noxo1-Noxa1 complex. Furthermore, we show that the mean migration directionality and velocity of epithelial cells were significantly enhanced by the inhibition of constitutive Nox1 activity. Thus, the constitutive Nox1 activity limits undesired cell migration in resting cells while participating in a positive feedback loop toward its own oxidase activity.
    MeSH term(s) Cell Movement ; Epithelial Cells/metabolism ; Humans ; NADPH Oxidase 1/metabolism ; Reactive Oxygen Species ; Transfection
    Chemical Substances Reactive Oxygen Species ; NADPH Oxidase 1 (EC 1.6.3.-) ; NOX1 protein, human (EC 1.6.3.-)
    Language English
    Publishing date 2020-09-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 1194130-3
    ISSN 1029-2470 ; 1071-5762
    ISSN (online) 1029-2470
    ISSN 1071-5762
    DOI 10.1080/10715762.2020.1823383
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The NADPH oxidase NOX4 promotes the directed migration of endothelial cells by stabilizing vascular endothelial growth factor receptor 2 protein.

    Miyano, Kei / Okamoto, Shuichiro / Yamauchi, Akira / Kawai, Chikage / Kajikawa, Mizuho / Kiyohara, Takuya / Tamura, Minoru / Taura, Masahiko / Kuribayashi, Futoshi

    The Journal of biological chemistry

    2020  Volume 295, Issue 33, Page(s) 11877–11890

    Abstract: Directed migration of endothelial cells (ECs) is an important process during both physiological and pathological angiogenesis. The binding of vascular endothelial growth factor (VEGF) to VEGF receptor-2 (VEGFR-2) on the EC surface is necessary for ... ...

    Abstract Directed migration of endothelial cells (ECs) is an important process during both physiological and pathological angiogenesis. The binding of vascular endothelial growth factor (VEGF) to VEGF receptor-2 (VEGFR-2) on the EC surface is necessary for directed migration of these cells. Here, we used TAXIScan, an optically accessible real-time horizontal cell dynamics assay approach, and demonstrate that reactive oxygen species (ROS)-producing NADPH oxidase 4 (NOX4), which is abundantly expressed in ECs, mediates VEGF/VEGFR-2-dependent directed migration. We noted that a continuous supply of endoplasmic reticulum (ER)-retained VEGFR-2 to the plasma membrane is required to maintain VEGFR-2 at the cell surface. siRNA-mediated NOX4 silencing decreased the ER-retained form of VEGFR-2, resulting in decreased cell surface expression levels of the receptor. We also found that ER-localized NOX4 interacts with ER-retained VEGFR-2 and thereby stabilizes this ER-retained form at the protein level in the ER. We conclude that NOX4 contributes to the directed migration of ECs by maintaining VEGFR-2 levels at their surface.
    MeSH term(s) Cell Line ; Cell Movement ; Endoplasmic Reticulum/metabolism ; Endothelial Cells/cytology ; Endothelial Cells/metabolism ; HeLa Cells ; Humans ; NADPH Oxidase 4/metabolism ; Protein Stability ; Reactive Oxygen Species/metabolism ; Vascular Endothelial Growth Factor Receptor-2/metabolism
    Chemical Substances Reactive Oxygen Species ; NADPH Oxidase 4 (EC 1.6.3.-) ; NOX4 protein, human (EC 1.6.3.-) ; KDR protein, human (EC 2.7.10.1) ; Vascular Endothelial Growth Factor Receptor-2 (EC 2.7.10.1)
    Language English
    Publishing date 2020-07-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.RA120.014723
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top